Cora Capital Advisors LLC Has $243,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cora Capital Advisors LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 462 shares of the healthcare conglomerate’s stock after selling 43 shares during the quarter. Cora Capital Advisors LLC’s holdings in UnitedHealth Group were worth $243,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of UNH. Verdence Capital Advisors LLC boosted its stake in shares of UnitedHealth Group by 2.1% in the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after buying an additional 342 shares during the period. Ascension Capital Advisors Inc. bought a new stake in UnitedHealth Group during the third quarter worth $216,000. Bellecapital International Ltd. lifted its stake in UnitedHealth Group by 1.4% during the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after purchasing an additional 193 shares during the last quarter. Great Valley Advisor Group Inc. lifted its stake in shares of UnitedHealth Group by 5.8% in the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after acquiring an additional 1,884 shares during the last quarter. Finally, Rise Advisors LLC lifted its stake in shares of UnitedHealth Group by 326.0% in the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock valued at $112,000 after acquiring an additional 163 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Up 0.3 %

NYSE UNH traded up $1.49 during trading hours on Friday, hitting $495.35. The company’s stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a market capitalization of $455.76 billion, a PE ratio of 30.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company’s 50-day simple moving average is $485.84 and its two-hundred day simple moving average is $514.07.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the firm earned $6.26 EPS. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is currently 45.97%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target for the company in a research note on Thursday, April 4th. Bank of America restated a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. TD Cowen decreased their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Truist Financial reiterated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, Barclays increased their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.